Baseline Serum Albumin and Its Dynamic Change is Associated with Type 2 Diabetes Risk: A Large Cohort in China.

Fulan Hu,Yanmei Lou,Jing Shi,Liming Cao,Changyi Wang,Jianping Ma,Xiaolin Peng,Shan Xu,Hongen Chen,Dan Zhao,Yang Zhao,Chunmei Guo,Dechen Liu,Qionggui Zhou,Quanman Li,Feiyan Liu,Gang Tian,Xiaoyan Wu,Ranran Qie,Minghui Han,Shengbing Huang,Ping Zhao,Ming Zhang,Dongsheng Hu,Pei Qin

DOI: https://doi.org/10.1002/dmrr.3296

2020-01-01

Abstract:Background The study aimed to investigate the associations of baseline serum albumin level and its dynamic change with type 2 diabetes mellitus (T2DM) risk in a large Chinese cohort study. Methods This cohort study included 30 442 adults without T2DM at first entry, who completed at least one follow-up of annual examinations between 2009 and 2016. Serum albumin level was measured at baseline and at every annual check-up. The dynamic change in serum albumin level ( increment ALB) was calculated by subtracting serum albumin level at baseline from that at the last follow-up. Hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with Cox regression models. Results During 7 years of follow-up, we identified 1634 T2DM events. From the lowest to the highest quartile of serum albumin level, adjusted HRs (95% CI) were 1.00 (reference), 0.96 (0.94, 1.01), 0.98 (0.95, 1.02) and 0.88 (0.85, 0.98), respectively. As compared with stable change in serum albumin (-0.2 <= increment ALB <1.0 g/L), the risk of T2DM increased for increment ALB < -2.0 g/L (HR 1.44, 95% CI 1.24-1.68) and decreased for increment ALB >= 3.0 g/L (0.81, 0.68-0.97) after adjusting for potential confounding factors. Restricted cubic splines showed a linear dose-response association between baseline serum albumin level and T2DM risk (P-nonlinearity 0.715) and a nonlinear dose-response association between increment ALB and T2DM risk (P-nonlinearity 0.011). Conclusions Baseline serum albumin level appears to be inversely associated with T2DM risk. Adults with reduced serum albumin level could be early identified for diabetes risk in clinical practice.